
Short-term intravenous interferon therapy for chronic hepatitis B
Author(s) -
Hiroaki Okushin,
Toru Ohnishi,
Kazuhiko Morii,
Katsuhiko Uesaka,
Shiro Yuasa
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.3038
Subject(s) - medicine , hbeag , gastroenterology , alpha interferon , seroconversion , pegylated interferon , hbsag , adverse effect , alanine transaminase , hepatitis b , immunology , interferon alfa , hepatitis b virus , interferon , pharmacology , chronic hepatitis , virus , ribavirin
To investigate the therapeutic efficacy of short-term, multiple daily dosing of intravenous interferon (IFN) in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.